This page will update you with the latest information from PGXIS including press releases, and announcements of our partnerships and collaborations.

For information or comment on PGXIS, please contact us in the UK or Japan, or e-mail us at info@pgxis.com



PGXIS Announces Merger with CytoPathfinder Inc

PGXIS has agreed to merge with Cytopathfinder Inc, a privately-owned company registered in Tokyo. The accompanying press release includes more information on CytoPathfinder and the synergy between the two companies.

PGXIS Merger Announcement Jun 09.pdf

PGXIS release latest Tax3 analysis

Tax3 analysis of flucolacillin-induced liver injury was presented at the 2nd International BIO-SI Workshop on Biostatistics held recently in Rennes, France.

Genetic epistasis analysis using taxonomy3.pdf